Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$385K Sell
2,615
-320
-11% -$52K 0.05% 77
2025
Q4
$572K Sell
2,935
-192
-6% -$45.7K 0.07% 64
2025
Q3
$879K Sell
3,127
-40
-1% -$10.2K 0.09% 51
2025
Q2
$692K Hold
3,167
0.1% 51
2025
Q1
$443K Buy
3,167
+7
+0.2% +$1.14K 0.08% 61
2024
Q4
$527K Hold
3,160
0.07% 57
2024
Q3
$538K Hold
3,160
0.09% 49
2024
Q2
$446K Hold
3,160
0.09% 51
2024
Q1
$397K Hold
3,160
0.09% 56
2023
Q4
$333K Hold
3,160
0.07% 64
2023
Q3
$335K Hold
3,160
0.07% 58
2023
Q2
$376K Hold
3,160
0.07% 51
2023
Q1
$294K Hold
3,160
0.07% 51
2022
Q4
$258K Buy
+3,160
New +$240K 0.09% 55
2022
Q3
Sell
-3,160
Closed -$221K 79
2022
Q2
$221K Hold
3,160
0.05% 66
2022
Q1
$261K Sell
3,160
-100
-3% -$8.1K 0.04% 61
2021
Q4
$284K Hold
3,260
0.06% 68
2021
Q3
$284K Sell
3,260
-55
-2% -$4.86K 0.06% 68
2021
Q2
$258K Sell
3,315
-375
-10% -$29.4K 0.03% 55
2021
Q1
$259K Buy
+3,690
New +$239K 0.04% 53

Other funds holding ORCL

Sloy Dahl & Holst's ORCL Position: Q1 2026 in Review

Sloy Dahl & Holst reduced its Oracle (ORCL) stake by 11% in Q1 2026, selling an estimated $52K and leaving 2,615 shares worth $385K. The position accounts for 0.05% of the portfolio, ranked #77.

Sloy Dahl & Holst first reported a position in ORCL in Q1 2021 and has held it in 20 quarters since. The position peaked at $879K in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Sloy Dahl & Holst held 2,615 shares of Oracle worth $385K as of Q1 2026.
  • Sloy Dahl & Holst sold 320 Oracle shares in Q1 2026, an estimated $52K.
  • Oracle made up 0.05% of Sloy Dahl & Holst's portfolio in Q1 2026, its #77 holding.
  • Sloy Dahl & Holst first reported a position in Oracle in Q1 2021 and has held it in 20 quarters since.
  • Sloy Dahl & Holst's Oracle position peaked at $879K in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Sloy Dahl & Holst's 13F filing for Q1 2026, filed 14 May 2026.